本文へ移動
cccskills

「therapy」の検索結果

152 件 ・ 関連度順

概要と使いどころ

心理咨询 / 心理治疗(临床实践者视角 — 接案与评估 / 个案概念化 / 主流流派技术(CBT 与第三浪潮 / 精神动力 / 人本存在 / 家庭系统 / 创伤治疗) / 伦理边界与危机干预 / 督导与个人成长 / 执业形态与经营 — 涵盖中国大陆行业现状 + 欧美持照体系,两套体系差异极大) (Psychotherapy & counseling — 心理咨询师 / 心理治疗师的临床实践(接案评估 / 个案概念化 / 主流流派技术 / 伦理与危机干预 / 督导成长 / 私人执业经营)) Master OS — automated mastery of Psychotherapy & counseling — 心理咨询师 / 心理治疗师的临床实践(接案评估 / 个案概念化 / 主流流派技术 / 伦理与危机干预 / 督导成长 / 私人执业经营): top builders' mental models, tool stack, current workflows, jargon, and where to keep up. Trigger this skill when the user works on Psychotherapy & counseling — 心理咨询师 / 心理治疗师的临床实践(接案评估 / 个案概念化 / 主流流派技术 / 伦理与危机干预 / 督导成长 / 私人执业经营) problems and wants industry-grade thinking, tool selection, or workflow guidance. 触发词:「心理咨询」「心理治疗」「psychotherapy」「counseling」「therapist」

日本語の概要は準備中です。原文の説明を表示しています。

swaylq/master-skill1492026年9月6日 更新

Comparison of the four guideline-approved psychotherapy approaches in Germany: Cognitive Behavioral Therapy, Psychodynamic Therapy, Psychoanalysis, Systemic Therapy — Orientation guide.

日本語の概要は準備中です。原文の説明を表示しています。

ellmos-ai/skills82026年10月12日 更新

This skill confirms that medical therapy has normalized cortisol before initiating radiation therapy or radiosurgery for Cushing's syndrome to maintain disease control while awaiting radiation effect. It is triggered when planning pituitary RT/radiosurgery for a patient with persistent or recurrent Cushing's disease after transsphenoidal surgery (TSS) or when medical therapy is being used as a bridge to radiation.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Think and work like an expert Immunotherapy Scientist. Use when a task calls for Immunotherapy Scientist judgment. Reasons from antigen recognition and checkpoint circuits through CAR-T/bispecific design, ASTCT CRS/ICANS grading, flow cytometry release CQAs, iRECIST response assessment, COMPASS/TIDE biomarker modeling, and JACIE/FACT IEC accreditation while treating antigen escape, pseudoprogression, tonic signaling, and step-up CRS as first-class failure modes.

日本語の概要は準備中です。原文の説明を表示しています。

K-Dense-AI/scientific-agents2002026年10月3日 更新

Think and work like an expert Gene Therapy Scientist. Use when a task calls for Gene Therapy Scientist judgment. Reasons from vector biology, biodistribution, linked potency, and integration risk through ddPCR titer, empty/full analytics, ISA and off-target NGS (GUIDE-seq, CIRCLE-seq), and ICH S12 nonclinical design while treating pre-existing capsid neutralizing antibodies, RCV/RCA/RCR positivity, gonadal vector genome, and oligoclonal VCN expansion as first-class failure modes.

日本語の概要は準備中です。原文の説明を表示しています。

K-Dense-AI/scientific-agents2002026年10月3日 更新

Evaluate therapy outcome measurement systems for rehabilitation and physical therapy.

日本語の概要は準備中です。原文の説明を表示しています。

tinh2/skills-hub-registry192026年9月5日 更新

Determines whether an adult patient meets eligibility criteria for initiating gender-affirming hormone therapy. Triggered when an adult patient requests gender-affirming hormones or presents for evaluation of hormone therapy eligibility.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Determines if a patient has completed ≥1 year of consistent and compliant hormone therapy for genital surgery approval. Triggers include patient requesting genital surgery and being on hormone therapy.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

This skill recommends measuring serum cortisol or urine free cortisol off-medication at 6- to 12-month intervals to assess radiation therapy effect in patients with Cushing's syndrome undergoing or post-radiotherapy. It is also indicated when patients on stable medical therapy develop new adrenal insufficiency symptoms such as fatigue, weight loss, or hypotension.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Solution-Focused Brief Therapy according to de Shazer and Berg: Miracle question, exception exploration, scaling, resource activation.

日本語の概要は準備中です。原文の説明を表示しています。

ellmos-ai/skills82026年10月12日 更新

Schema Therapy according to Jeffrey Young: Schemas, modes, inner child concept, and coping styles — psychoeducationally presented.

日本語の概要は準備中です。原文の説明を表示しています。

ellmos-ai/skills82026年10月12日 更新

调香师与香水 (调香师 / 香水 (Perfumery & Fragrance) — 香水创作与香气调配的职业认知操作系统,从业者/调香师/评香师/学习者视角。覆盖: (a) 第一性张力 — codifiable 理论层 (原料知识/香料化学/嗅觉家族分类/accord 和弦/配方结构 %/挥发度金字塔/IFRA 法规) ⇄ tacit 校准层 (嗅觉记忆/闻香训练/「the nose」/创作直觉/盲嗅识别),这行的核心矛盾是「可背诵的原料与公式」与「不可言传的嗅觉记忆与品味」之间,嗅觉记忆是极致 tacit 技能; (b) 法系传统 vs 分子/合成派 — 法国 Grasse 天然香料 + haute parfumerie 艺术传统 (天然精油/原精/学徒制) vs 现代分子派 (aroma chemicals 香基/captives 专利分子/headspace 顶空捕香/功能香精),两套对「香水是什么」的世界观; (c) 培养/传承 — ISIPCA (凡尔赛香水学校) + 四大香精公司内部调香学校 (Givaudan/Firmenich(DSM-Firmenich)/IFF/Symrise) + 学徒制 + 「鼻子」tacit 校准; 角色分工: perfumer(parfumeur 调香师) vs evaluator(评香师) vs flavorist(食用香精师); (d) 行业结构 — 四大香精公司寡头 (Givaudan/DSM-Firmenich/IFF/Symrise) + Mane/Robertet/Takasago,为品牌做 B2B 命题创作 (the brief → creation → mods 模型); vs niche/indie 小众独立香水 (artisanal/直营); 天然 (Grasse/精油) vs 合成 (香基/captives) 的成本与可持续之争; (e) 创作层 — 香调金字塔 (top/heart/base notes 前中后调)、accord 和弦、配方 (酒精中 % 浓度)、浓度分级 (parfum/EDP/EDT/EDC)、调香师的「香风琴」orgue、trials/mods 试样迭代、weighing 称量精度; (f) 法规与安全 — IFRA standards (原料限用)、EU 致敏原标签 (26→80+ allergens)、REACH、橡苔/atranol 限用、经典香水 (Mitsouko/Chanel No.5) 因法规被迫重配 (reformulation) 与创作自由之张力; (g) 评价/批评 — Luca Turin & Tania Sanchez (《Perfumes: The Guide》《The Secret of Scent》气味的科学)、香评人、Fragrantica/Basenotes 社区、vintage vs reformulation 之争、niche vs designer 之争。学派分歧: 法系天然传统派 vs 分子合成派、天然纯粹派 vs 合成实用派、haute parfumerie/niche 艺术派 vs mass designer 商业派、「鼻子=艺术家」vs「调香师=香气工程师/技师」、嗅觉科学之争 (Luca Turin 振动理论 vs 主流形状/受体理论)。不含: 香薰蜡烛/家居香氛纯生产营销、芳香疗法健康宣称 (aromatherapy)、纯化妆品配方学 (超出香精范畴)、DIY 家用香氛套件、精油传销/MLM。) Master OS — automated mastery of 调香师 / 香水 (Perfumery & Fragrance) — 香水创作与香气调配的职业认知操作系统,从业者/调香师/评香师/学习者视角。覆盖: (a) 第一性张力 — codifiable 理论层 (原料知识/香料化学/嗅觉家族分类/accord 和弦/配方结构 %/挥发度金字塔/IFRA 法规) ⇄ tacit 校准层 (嗅觉记忆/闻香训练/「the nose」/创作直觉/盲嗅识别),这行的核心矛盾是「可背诵的原料与公式」与「不可言传的嗅觉记忆与品味」之间,嗅觉记忆是极致 tacit 技能; (b) 法系传统 vs 分子/合成派 — 法国 Grasse 天然香料 + haute parfumerie 艺术传统 (天然精油/原精/学徒制) vs 现代分子派 (aroma chemicals 香基/captives 专利分子/headspace 顶空捕香/功能香精),两套对「香水是什么」的世界观; (c) 培养/传承 — ISIPCA (凡尔赛香水学校) + 四大香精公司内部调香学校 (Givaudan/Firmenich(DSM-Firmenich)/IFF/Symrise) + 学徒制 + 「鼻子」tacit 校准; 角色分工: perfumer(parfumeur 调香师) vs evaluator(评香师) vs flavorist(食用香精师); (d) 行业结构 — 四大香精公司寡头 (Givaudan/DSM-Firmenich/IFF/Symrise) + Mane/Robertet/Takasago,为品牌做 B2B 命题创作 (the brief → creation → mods 模型); vs niche/indie 小众独立香水 (artisanal/直营); 天然 (Grasse/精油) vs 合成 (香基/captives) 的成本与可持续之争; (e) 创作层 — 香调金字塔 (top/heart/base notes 前中后调)、accord 和弦、配方 (酒精中 % 浓度)、浓度分级 (parfum/EDP/EDT/EDC)、调香师的「香风琴」orgue、trials/mods 试样迭代、weighing 称量精度; (f) 法规与安全 — IFRA standards (原料限用)、EU 致敏原标签 (26→80+ allergens)、REACH、橡苔/atranol 限用、经典香水 (Mitsouko/Chanel No.5) 因法规被迫重配 (reformulation) 与创作自由之张力; (g) 评价/批评 — Luca Turin & Tania Sanchez (《Perfumes: The Guide》《The Secret of Scent》气味的科学)、香评人、Fragrantica/Basenotes 社区、vintage vs reformulation 之争、niche vs designer 之争。学派分歧: 法系天然传统派 vs 分子合成派、天然纯粹派 vs 合成实用派、haute parfumerie/niche 艺术派 vs mass designer 商业派、「鼻子=艺术家」vs「调香师=香气工程师/技师」、嗅觉科学之争 (Luca Turin 振动理论 vs 主流形状/受体理论)。不含: 香薰蜡烛/家居香氛纯生产营销、芳香疗法健康宣称 (aromatherapy)、纯化妆品配方学 (超出香精范畴)、DIY 家用香氛套件、精油传销/MLM。: top builders' mental models, tool stack, current workflows, jargon, and where to keep up. Trigger this skill when the user works on 调香师 / 香水 (Perfumery & Fragrance) — 香水创作与香气调配的职业认知操作系统,从业者/调香师/评香师/学习者视角。覆盖: (a) 第一性张力 — codifiable 理论层 (原料知识/香料化学/嗅觉家族分类/accord 和弦/配方结构 %/挥发度金字塔/IFRA 法规) ⇄ tacit 校准层 (嗅觉记忆/闻香训练/「the nose」/创作直觉/盲嗅识别),这行的核心矛盾是「可背诵的原料与公式」与「不可言传的嗅觉记忆与品味」之间,嗅觉记忆是极致 tacit 技能; (b) 法系传统 vs 分子/合成派 — 法国 Grasse 天然香料 + haute parfumerie 艺术传统 (天然精油/原精/学徒制) vs 现代分子派 (aroma chemicals 香基/captives 专利分子/headspace 顶空捕香/功能香精),两套对「香水是什么」的世界观; (c) 培养/传承 — ISIPCA (凡尔赛香水学校) + 四大香精公司内部调香学校 (Givaudan/Firmenich(DSM-Firmenich)/IFF/Symrise) + 学徒制 + 「鼻子」tacit 校准; 角色分工: perfumer(parfumeur 调香师) vs evaluator(评香师) vs flavorist(食用香精师); (d) 行业结构 — 四大香精公司寡头 (Givaudan/DSM-Firmenich/IFF/Symrise) + Mane/Robertet/Takasago,为品牌做 B2B 命题创作 (the brief → creation → mods 模型); vs niche/indie 小众独立香水 (artisanal/直营); 天然 (Grasse/精油) vs 合成 (香基/captives) 的成本与可持续之争; (e) 创作层 — 香调金字塔 (top/heart/base notes 前中后调)、ac

日本語の概要は準備中です。原文の説明を表示しています。

swaylq/master-skill1492026年9月6日 更新

健身私教 — 为客户设计、指导和推进个性化训练方案的专业工艺, 有别于团课教练、物理治疗师或运动队教练: (a) 训练方案设计与周期化 (线性 / 波动 / 板块周期化 Bompa & Haff; NSCA《力量训练与体能训练精要》行业圣经; Schoenfeld 肌肥大机制; Helms/Valdez/Morgan 肌肉与力量金字塔; 共轭训练法 Simmons/Westside; Starting Strength 线性渐进 Rippetoe; Renaissance Periodization 训练量地标 Israetel); (b) 动作评估与筛查 (FMS 功能性动作筛查 Gray Cook; NASM CEx 纠正性训练连续体 抑制-拉伸-激活-整合; 关节逐级方法 Cook/Boyle; 姿势与代偿模式识别; PAR-Q+ 与 ACSM 运动前筛查指南); (c) 教学与指令 (外部 vs 内部注意焦点 Wulf; 差异化学习 Schöllhorn; 约束导向方法 Davids/Renshaw; RIR/RPE 自动调节 Zourdos/Helms; 动机访谈在健身中的应用 Rollnick/Miller); (d) 营养指导的执业边界 (宏量营养素周期化; Precision Nutrition / ISSN 立场声明的循证建议; 边界: 私教提供一般性指导, 医学营养治疗需 RD/RDN 资质; 能量可用性与 RED-S Mountjoy IOC 共识); (e) 商业与客户管理 (客户留存与方案依从; 咨询与销售伦理; 线上教练平台与规模化 Goodman PTDC; 方案交付工具 TrueCoach/Trainerize/TrainHeroic; 课时定价模型; 独立教练 vs 健身房雇员); (f) 专项方向 (运动表现 CSCS; 纠正性训练 CES; 老年健身 SFN; 产前产后; 青少年 YSCA; 适应性 / 无障碍健身; 健美 / 形体; 力量举; 耐力运动 S&C)。诚实处理: 兄弟科学 vs 循证之争, 补剂行业利益冲突, 合成代谢激素使用现状 (诚实但不推广: 匿名调查约 30% 有经验男性健身者使用过 — 业内估, Kanayama/Pope/Hudson 记录健康风险, WADA 禁用清单用于竞技语境), 体型焦虑与进食障碍风险 (男性私教肌肉变形症, 正食症倾向, NEDA 负责任语言指南), 健身房掠夺性销售 (高压推销、误导性对比照、长约锁定), 执业边界违规 (私教诊断伤病或超范围开饮食处方), 线上教练认证造假 (周末速成、未经认可的认证)。不含: 物理治疗 / 康复治疗 (持照医疗职业), 不含: 团课教练 (Les Mills/Zumba/CrossFit 分馆教练 — 相邻但不同), 不含: 精英竞技运动教练 (团队项目周期化, 不同职业路径), 不含: 营养作为主业 (临床营养学需单独资质)。 (Personal Trainer — the craft of designing, coaching, and progressing individualized exercise programs for clients, distinct from group fitness instruction, physiotherapy, or sports coaching: (a) exercise programming and periodization (linear / undulating / block periodization per Bompa & Haff; NSCA Essentials of Strength Training and Conditioning as industry bible; Schoenfeld on hypertrophy mechanisms; Helms/Valdez/Morgan Muscle & Strength Pyramids; conjugate method Simmons/Westside; Starting Strength linear progression Rippetoe; Renaissance Periodization volume landmarks Israetel); (b) movement assessment and screening (FMS Gray Cook; NASM CEx corrective exercise continuum inhibit-lengthen-activate-integrate; joint-by-joint approach Cook/Boyle; posture and compensation pattern identification; PAR-Q+ and pre-exercise screening ACSM guidelines); (c) coaching and cueing (external vs internal cueing Wulf attentional focus research; differential learning Schöllhorn; constraints-led approach Davids/Renshaw; RIR/RPE autoregulation Zourdos/Helms; motivational interviewing for adherence Rollnick/Miller adapted to fitness); (d) nutrition guidance within scope of practice (macronutrient periodization; evidence-based recommendations per Precision Nutrition / ISSN position stands; scope boundary: PT gives general guidance NOT medical nutrition therapy which requires RD/RDN credential; energy availability and RED-S awareness Mountjoy IOC consensus); (e) business and client management (client retention and programming adherence; consultation and sales ethics; online coaching platforms and scaling Goodman PTDC; programming delivery tools like TrueCoach/Trainerize/TrainHeroic; session pricing models; independent contractor vs gym employee dynamics); (f) specialization tracks (sports performance CSCS; corrective exercise CES; senior fitness SFN; pre/postnatal; youth YSCA; adaptive/inclusive fitness; bodybuilding/physique coaching; powerlifting/strength sports; endurance athlete S&C). Evidence-based practice as the core ethos: Schoenfeld/Krieger meta-analyses on volume-response, Helms systematic reviews on protein/resistance training, Brad Schoenfeld's MASS journal bridging research to practice, Menno Henselmans and Eric Helms as practitioner-researchers, Greg Nuckols Stronger By Science as translation layer. Chinese fitness industry context: rapid growth of personal training in commercial gyms (Keep/Lefit/Megafit chains), NSCA-CPT and ACE-CPT as dominant certifications alongside local CSFA (China Sport and Fitness Association) credential, '体适能' (physical fitness) as formal term, online coaching boom post-COVID, PT business models in tier 1-3 cities diverge sharply. Honest treatment of: bro science vs evidence-based d

日本語の概要は準備中です。原文の説明を表示しています。

swaylq/master-skill1492026年9月6日 更新

Use when a task needs the judgment of an Art Therapist — matching art media to a client's regulation capacity via the Expressive Therapies Continuum, scoring a standardized directive (PPAT, KFD, DAP) with a validated instrument like FEATS as part of assessment, deciding between a directive and open-studio session structure, navigating informed consent and disposition for client-made artwork, or distinguishing an art-as-therapy approach from an art-psychotherapy approach for a given client.

日本語の概要は準備中です。原文の説明を表示しています。

wonsukchoi/domain-experts202026年10月12日 更新

Evaluate physical therapy personalization and adaptive treatment systems.

日本語の概要は準備中です。原文の説明を表示しています。

tinh2/skills-hub-registry192026年9月5日 更新

Audit a rehabilitation or physical therapy platform end-to-end -- evaluate recovery metrics tracking (ROM, strength, balance, gait), patient-reported outcomes (DASH, LEFS, NDI, ODI, PROMIS), home exercise program personalization and compliance tracking.

日本語の概要は準備中です。原文の説明を表示しています。

tinh2/skills-hub-registry192026年9月5日 更新

Expert in cluttering -- the lesser-known fluency disorder characterized by rapid/irregular speech rate, excessive disfluencies, and frequent ADHD comorbidity. Covers differential diagnosis from stuttering, assessment protocols, therapy approaches (rate control, self-monitoring, pragmatic awareness), technology-assisted intervention, and AI tools for people who clutter. Activate on 'cluttering', 'rapid speech disorder', 'speech rate too fast', 'speech disfluency not stuttering', 'disorganized speech', 'ADHD speech problems', 'cluttering vs stuttering', 'speech intelligibility', 'mazed speech', 'telescoping words'. NOT for stuttering-only treatment (overlap is common but they are distinct), hearing disorders, or voice disorders (pitch, resonance).

日本語の概要は準備中です。原文の説明を表示しています。

curiositech/windags-skills132026年10月12日 更新

Provides monitoring schedule for transgender males on testosterone therapy, detailing timing of clinical visits, laboratory tests, and assessment for virilization and adverse reactions. It is triggered when a clinician manages a transgender male patient on gender‑affirming hormone therapy and needs to schedule appropriate follow‑up.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Provides a monitoring schedule for patients receiving GnRH agonist therapy for pubertal suppression. Trigger phrases include 'patient undergoing GnRH agonist therapy' or 'initiating pubertal suppression'.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

This skill confirms whether a hospital has the necessary policies and expertise to support inpatient insulin pump therapy, including informed consent, standardized order sets, and device management guidance for imaging and surgical procedures. Triggered by questions such as "Are hospital policies and expertise in place for insulin pump use?" to ensure safe continuation of pump therapy in noncritical illness.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Evaluates cardiovascular risk factors in persons receiving hormone therapy by obtaining fasting lipid profiles and diabetes screening. Triggered when a patient is on gender-affirming hormone therapy and due for routine cardiovascular risk assessment.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Considers adapting the basal insulin rate at hospital admission for patients using insulin pump therapy. Triggered by clinician questions such as "Should we adjust the basal rate upon admission for pump therapy?" or when evaluating pump continuation versus transition to scheduled subcutaneous insulin.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

This skill guides clinicians to inform and counsel individuals seeking gender-affirming medical treatment about fertility preservation options before initiating puberty suppression in adolescents or before starting hormonal therapy in adolescents and adults. It is triggered when a patient is eligible for pubertal suppression or sex hormone treatment and is about to begin such therapy.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

This skill determines whether testicular volume should be used as the primary or sole indicator of sexual development in male childhood cancer survivors who have received gonadotoxic treatments such as alkylating agents or testicular radiotherapy. Triggers include clinician questions like “Can I use testicular volume to assess puberty in this male survivor after chemotherapy?” or “Is testis size reliable for sexual maturity evaluation post‑radiation?”

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新